Effectiveness of Text Messaging Intervention to Improve Dietary Behaviors Among Patients with Type 2 Diabetes Mellitus in Low Resource Area of Sabah (DTEXT-SBH)
NCT ID: NCT06587581
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
62 participants
INTERVENTIONAL
2025-01-31
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does a mobile phone text-message intervention improve dietary adherence among T2DM patients?
* Does a mobile phone text-message intervention improve HbA1c and self-management among T2DM patients? Researchers will compare dietary adherence, HbA1c changes and self-management behaviors between the usual care group and intervention group.
Participants will:
* Be given three (3) text messages per week over a six (6) months period for the intervention group
* Both usual care and intervention group will be given standard medical nutrition therapy at baseline, 3rd and 6th months visits to the clinic
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Text Messaging and Cardiovascular Health in Diabetes Mellitus
NCT03724526
Personalized Diabetes Text Messaging (DB-TEXT) Combined With Peer Support Education in Patients With Type 2 Diabetes
NCT05629117
mHealth Intervention to Support Diabetes Medication Adherence (Pilot Study)
NCT04738591
Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes
NCT01403831
Post Trial Analysis of a Primary Prevention Study in Asian Indians
NCT02848547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T2DM Medical Nutrition Therapy
Participants from control groups will receive the usual care, which will be a three-monthly nutrition consultation by a visiting dietitian
Control Group
Participants from the intervention group will receive the usual care over the 6-month intervention period
T2DM Medical Nutrition Therapy and Text Messages
Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period
Intervention Group
Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control Group
Participants from the intervention group will receive the usual care over the 6-month intervention period
Intervention Group
Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* own a mobile phone.
* able to use WhatsApp.
* able to read and speak Bahasa Malaysia.
* have an HbA1c level above 7.0%.
* have not seen a dietitian in the previous 6 months.
Exclusion Criteria
* patients with cognitive impairment affecting memory, attention, language, and problem-solving skills.
* those with advanced diabetic complications, such as kidney failure and neuropathy.
* individuals lacking regular access to a mobile phone or with poor network connectivity.
* pregnant individuals or those planning to get pregnant in the next 6 months, as well as those currently nursing.
* individuals with major illnesses like cancer or advanced heart disease.
* those planning major surgery or gastric bypass in the next 6 months.
* institutionalized individuals, such as those in nursing homes, old folks\' homes, or imprisoned.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Malaysia Sabah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ESTHER ALIM ALBERT
REGISTERED DIETITIAN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ranau District Hospital and Klinik Kesihatan Kundasang
Kota Kinabalu, Sabah, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Esther Alim Albert
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014 Jun;63(6):745-54.e6. doi: 10.1016/j.annemergmed.2013.10.012. Epub 2013 Nov 11.
Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8. doi: 10.1016/S2213-8587(13)70067-6. Epub 2013 Sep 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RSCH ID-24-01119-NHX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.